Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 4 · Randomised trials: 2 · 1999–2026
Showing the 50 most relevant studies, sorted by most relevant.
N. Herawati *, , S. Suzuki, K. Hayashi, I. F. Rivai
Bulletin of Environmental Contamination and Toxicology, 2000
Jochanan E. Naschitz, Gleb Slobodin, Roger J. Lewis, et al.
American Heart Journal, 2000
Heitor O. Santos, T. May, A. Bueno
Frontiers in Nutrition, 2023
Antony E. Nicoll, Fiona Mackenzie, Ian A. Greer, et al.
American Journal of Obstetrics and Gynecology, 2001
Anthony M. D'Alessandro, Robert M. Hoffmann, Stuart J. Knechtle, et al.
Surgery, 2000
Girotra V, Kaushik P, Vaya D
2024
This comprehensive review delves into the burgeoning field of nanotechnology, where the synthesis of nanoparticles (NPs) is strategically tailored to specific applications. Embracing the principles of green chemistry, nanotechnology increasingly utilizes environmentally friendly materials, such as plant extracts or microorganisms, as capping or reducing agents and solvents in the synthesis process. Notably, plant-based synthesis demonstrates enhanced stability and faster rates compared to microorganisms. The synthesized materials exhibit unique properties ranging from antimicrobial and catalytic effects to antioxidant activities and they are finding applications across diverse fields. Green synthesis processes, characterized by mild conditions in terms of temperature and reagents, stand in stark contrast to traditional chemical synthesis methods. This review focuses on the synthesis of various metal and metal oxide NPs, including Ag, Au, Zn, Fe, Mg, Ti, Sn, Cu, Cd, Ni, Co, and Ag NPs and their oxides, using plant extracts and microorganisms. We provide a comprehensive analysis of the advantages, disadvantages, and applications associated with each synthesis method. Additionally, we explore the future prospects of green synthesis and its limitations and challenges, offering insights into its evolving role in nanotechnology.
Abstract licence: CC BY
Lorenzo Capussotti, Vincenzo Vergara, Roberto Polastri, et al.
Surgery, 2000
Morasiewicz-Jeziorek J, Buczyńska A, Krętowski AJ, et al.
2026
- Diet
- Oxidative Stress
- Hashimoto Disease
Hashimoto thyroiditis (HT) is an autoimmune thyroid disorder characterized by chronic inflammation and hypothyroidism. The current scientific understanding indicates that the development of HT is influenced by a combination of genetic and environmental factors. Nevertheless, oxidative stress (OS) and dysregulated immune processes play a substantial role in HT pathogenesis. Reactive oxygen species (ROS) play a critical role in thyroid hormone synthesis by facilitating iodide oxidation. Since thyroid hormones influence mitochondrial activity and regulate ROS production, the thyroid gland is particularly vulnerable to OS and disruptions in homeostasis. Research indicates that, in HT, the oxidative balance shifts toward a pro-oxidative state. Excessive levels of ROS disrupt cellular homeostasis and induce inflammation, leading to structural and functional damage of thyroid tissue. These processes play a substantial role in the pathogenesis and progression of HT. Among the various environmental factors that can be modulated, dietary nutrients are considered one of the most promising and underappreciated clinical tools in this process. The primary aim was to explore the potential role of dietary interventions in protecting thyroid function, supporting the immune response, and alleviating OS in individuals with HT. According to the literature data, proper nutrition in HT should include sufficient amounts of anti-inflammatory components. These emphasize the role of mono- and polyunsaturated fatty acids (such as omega-3, omega-6), polyphenols, whey protein, soy protein, and isoflavones. Moreover, a well-balanced and varied diet rich in antioxidants, including vitamins C and E, selenium, zinc, and polyphenols, may help reduce OS in HT, simultaneously modulating the immunological processes. Additionally, it is essential to ensure an adequate intake of micronutrients, including iodine, iron, selenium, and vitamins, especially vitamin D, to support thyroid homeostasis. Adopting a balanced and nutrient-rich diet, along with specific dietary patterns, may be beneficial in managing the symptoms and improving the overall well-being of individuals with HT.
Abstract licence: CC BY-NC-ND
Danielle S. Walsh, Anne M. Hubbard, Oluyinka O. Olutoye, et al.
American Journal of Obstetrics and Gynecology, 2000
Han Ping Shi, David T. Efron, Daniel Most, et al.
Surgery, 2000
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.